(Dana-Farber Cancer Institute) Some patients with a form of advanced kidney cancer benefited from an experimental drug targeted to an abnormal genetic pathway causing cancerous growth, according to research led by Dana-Farber Cancer Institute scientists. (Source: EurekAlert! - Cancer)
from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2sLoXmI
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,